Identification of an oculomotor biomarker of preclinical Huntington disease.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 16625001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors examined oculomotor function to identify a biomarker of disease progression in genetically confirmed preclinical and early clinical Huntington disease (HD). Initiation deficits of voluntary-guided, but not reflexive, saccades were characteristic of preclinical HD. Saccadic slowing and delayed reflexive saccades were demonstrated in clinical but not preclinical HD. Saccadic measures provide biomarkers of disease progression in both preclinical and early clinical stages of HD.
Medical subject headings
- Huntington Disease
- Ocular Motility Disorders
- Saccades